27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Get in on the action here.
Ronald W. Penczek, insider at Elevance Health

Ronald W. Penczek Insider Information

Ronald W. Penczek is a Senior Vice President, Chief Accounting Officer, Controller of the Company. Prior to that appointment, Mr. Penczek served as Vice President and Assistant Controller from January 2008 to August 2013 and in various other roles in our finance department from February 2006 until January 2008. Before joining us, Mr. Penczek was a Staff Vice President with CNA Insurance from 2000 to 2005 and had various positions with PricewaterhouseCoopers LLP from 1992 to 2000, including as a Manager.

What is Ronald W. Penczek's net worth?

The estimated net worth of Ronald W. Penczek is at least $1.52 million as of March 5th, 2021. Mr. Penczek owns 3,137 shares of Elevance Health stock worth more than $1,524,519 as of July 3rd. This net worth approximation does not reflect any other assets that Mr. Penczek may own. Learn More about Ronald W. Penczek's net worth.

How old is Ronald W. Penczek?

Mr. Penczek is currently 57 years old. There are 6 older executives and no younger executives at Elevance Health. The oldest executive at Elevance Health is Ms. Gloria Marie McCarthy, Exec. VP & Chief Admin. Officer, who is 69 years old. Learn More on Ronald W. Penczek's age.

How do I contact Ronald W. Penczek?

The corporate mailing address for Mr. Penczek and other Elevance Health executives is 220 VIRGINIA AVENUE, INDIANAPOLIS IN, 46204. Elevance Health can also be reached via phone at (800) 331-1476 and via email at [email protected] Learn More on Ronald W. Penczek's contact information.

Has Ronald W. Penczek been buying or selling shares of Elevance Health?

Ronald W. Penczek has not been actively trading shares of Elevance Health in the last ninety days. As far as recent transactions, on Sunday, July 3rd, 0 shares of BMO Capital Markets stock. Learn More on Ronald W. Penczek's trading history.

Who are Elevance Health's active insiders?

Elevance Health's insider roster includes Gail Boudreaux (CEO), Robert Dixon, Jr. (Director), John Gallina (CFO), Brian Griffin (CEO), Peter Haytaian (EVP), Julie Hill (Director), Charles Kendrick, Jr. (EVP), Gloria Mccarthy (EVP), Ronald Penczek (CAO), Ramiro Peru (Director), Craig Samitt (EVP), Ryan Schneider (Director), Joseph Swedish (Insider), Jose Tomas (EVP), and Thomas Zielinski (EVP). Learn More on Elevance Health's active insiders.

Are insiders buying or selling shares of Elevance Health?

In the last year, Elevance Health insiders bought shares 1 times. They purchased a total of 1,300 shares worth more than $499,668.00. In the last year, insiders at the sold shares 7 times. They sold a total of 31,777 shares worth more than $14,798,661.81. The most recent insider tranaction occured on June, 9th when EVP Charles Morgan Kendrick Jr sold 6,328 shares worth more than $3,091,860.80. Insiders at Elevance Health own 0.3 % of the company. Learn More about insider trades at Elevance Health.

Information on this page was last updated on 6/9/2022.

Ronald W. Penczek Insider Trading History at Elevance Health

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/3/2022Sell2,423$463.68$1,123,496.64View SEC Filing Icon  
2/7/2022Sell2,763$453.48$1,252,965.24View SEC Filing Icon  
10/28/2021Sell1,150$436.00$501,400.00View SEC Filing Icon  
3/5/2021Sell2,068$333.94$690,587.923,137View SEC Filing Icon  
11/13/2019Sell816$287.00$234,192.002,295View SEC Filing Icon  
5/30/2019Sell763$279.00$212,877.002,295View SEC Filing Icon  
9/4/2018Sell763$265.56$202,622.281,334View SEC Filing Icon  
3/7/2018Sell1,966$231.90$455,915.402,132View SEC Filing Icon  
11/7/2017Sell978$217.42$212,636.761,222View SEC Filing Icon  
6/7/2017Sell867$187.46$162,527.821,872View SEC Filing Icon  
3/6/2017Sell729$165.56$120,693.241,448View SEC Filing Icon  
3/2/2017Sell1,213$166.56$202,037.281,248View SEC Filing Icon  
11/22/2016Sell820$138.29$113,397.801,320View SEC Filing Icon  
8/3/2016Sell552$128.37$70,860.242,407View SEC Filing Icon  
See Full Table

Ronald W. Penczek Buying and Selling Activity at Elevance Health

This chart shows Ronald W Penczek's buying and selling at Elevance Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Elevance Health Company Overview

Elevance Health logo
Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through four segments: Commercial & Specialty Business, Government Business, IngenioRx, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small groups, individuals, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products. The company also provides a range of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical management, disease management, wellness programs, and other administrative services. In addition, it offers an array of specialty and other insurance products and services, such as pharmacy benefits management, dental, vision, life and disability insurance benefits, and analytics-driven personal health care. Further, the company provides services to the federal government in connection with the Federal Employee Program; and operates as a licensee of the Blue Cross and Blue Shield Association. As of December 31, 2021, it served 45 million medical members through its affiliated health plans. The company was formerly known as WellPoint, Inc. and changed its name to Anthem, Inc. in December 2014. Anthem, Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Read More

Today's Range

Now: $485.98
Low: $469.80
High: $486.82

50 Day Range

MA: $489.85
Low: $444.32
High: $520.55

2 Week Range

Now: $485.98
Low: $355.43
High: $533.68

Volume

997,302 shs

Average Volume

1,098,563 shs

Market Capitalization

$117.16 billion

P/E Ratio

19.13

Dividend Yield

1.05%

Beta

0.95
27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Get in on the action here.